Login / Signup

Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.

Sébastien HascoetJames R BenthamLuca GiugnoPedro Betrián-BlascoAleksander KempnyAli HoueijehHaysam BahoShiv-Raj SharmaMatthew I JonesElżbieta Katarzyna BiernackaNicolas CombesStainimir GeorgievHelene BouvaistJosé Diogo MartinsMarinos KantzisMark TurnerStephan SchubertZakaria JalalGianfranco ButeraSophie-Guiti Malekzadeh-MilaniEstibaliz ValdeolmillosClement KarsentyEnder ÖdemişPhilippe AldebertNikolaus A HaasIhab KhatibHåkan WåhlanderGianpiero GaioAlberto MendozaSayqa ArifBiagio CastaldiGaute DohlenRonald G CarereMaría Jesús Del Cerro MarínErwin KitzmüllerAntony HermuziMario CarminatiPatrice GuerinAnja LehnerAlain Fraissenull null
Published in: European heart journal (2023)
Outcomes of SAPIEN 3 TPVI were favourable in patients with CHD, half of whom had native or patched RVOTs.
Keyphrases
  • transcatheter aortic valve replacement
  • transcatheter aortic valve implantation
  • aortic valve
  • pulmonary hypertension
  • mitral valve
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • glycemic control
  • left ventricular